Keywords: درمان آندروژن محروم; Prostate cancer; Androgen-deprivation therapy; Complete Androgen Blockade (CAB); Type 2 diabetes (T2DM); Insulin resistance; Insulin deficiency;
مقالات ISI درمان آندروژن محروم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان آندروژن محروم; Buserelin; Nilutamide; Advanced prostate cancer; Androgen-deprivation therapy; Buserelina; Nilutamida; Cáncer prostático avanzado; Terapia de privación androgénica;
Keywords: درمان آندروژن محروم; Prostate cancer; Castration-sensitive prostate cancer; Oligometastasis; Androgen-deprivation therapy; Docetaxel chemotherapy; Stereotactic ablative radiotherapy;
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Docetaxel; Estrogen; Phase II; PSA;
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Hormones; Intermediate-risk; NCDB; Prostate cancer; Radiation therapy;
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Bone mineral density; Prostate cancer; Transdermal oestradiol;
Keywords: درمان آندروژن محروم; androgen-deprivation therapy; matrix metalloproteinases; metastasis; prostate cancer
Keywords: درمان آندروژن محروم; Prostate cancer; Androgen-deprivation therapy; Castration resistant; Wnt; β-catenin;
Keywords: درمان آندروژن محروم; Prostate cancer; Androgen-deprivation therapy; Prostate-specific antigen;
Keywords: درمان آندروژن محروم; ADT; androgen-deprivation therapy; CLPC; clinically localized prostate cancer; HR; hazard ratio; SEER; Surveillance, Epidemiology, and End Results;
Keywords: درمان آندروژن محروم; Prostate cancer; Androgen-deprivation therapy; Diabetes
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Imaging; Lymph node positive metastasis; Multimodality; Pelvic lymph node dissection; Prostate cancer; Radical prostatectomy; Radiotherapy
Adjuvant androgen-deprivation therapy following prostate total cryoablation in high-risk localized prostate cancer patients - Open-labeled randomized clinical trial
Keywords: درمان آندروژن محروم; Cryotherapy; Cryosurgery; Prostate tumor; Hormone therapy; Complication; ADT; Androgen-deprivation therapy; HRLPC; High-risk localized prostate cancer; TGC; Total-gland cryoablation;
Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
Keywords: درمان آندروژن محروم; CCL2; chemokine CC motif ligand 2; CRPC; castration-resistance prostate cancer; AR; androgen receptor; EMT; epithelial-to-mesenchymal transition; SPDEF; SAM pointed domain-containing ETS transcription factor; ADT; androgen-deprivation therapy; PTEN; phosp
A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients
Keywords: درمان آندروژن محروم; 3β-HSD1; 3β-hydroxysteroid dehydrogenase/Î5â4 isomerase 1; CYP17A1; 17αâhydroxylase/17,20âlyase; Î4A; Î4-abiraterone; ABI; abiraterone; ADT; androgen-deprivation therapy; Cmin; mean of trough plasma concentrations measured during the first thr
Retrospective Review of Percutaneous Image-Guided Ablation of Oligometastatic Prostate Cancer: A Single-Institution Experience
Keywords: درمان آندروژن محروم; ADT; androgen-deprivation therapy; CRPC; castrate-resistant prostate cancer; PET; positron emission tomography; PFS; progression free survival; PSA; prostate-specific antigen; SBRT; stereotactic body radiation therapy;
Can androgen-deprivation therapy obviate the need of channel transurethral resection of the prostate in advanced prostate cancer with urinary retention? A prospective study
Keywords: درمان آندروژن محروم; ADT; androgen-deprivation therapy; AUR; acute urinary retention; pTURP; palliative TURP; TWOC; trial of voiding without catheter; USG KUB; ultrasonography of the kidney, ureter and bladder; ADT; ADT in retention; Prostate cancer;
Evaluation of a supervised multi-modal physical exercise program for prostate cancer survivors in the rehabilitation phase: Rationale and study protocol of the ProCaLife study
Keywords: درمان آندروژن محروم; 6MWT; six-minute walk test; ADT; androgen-deprivation therapy; ANOVA; analysis of variance; ATS; American Thoracic Society; BAQ; Baecke Activity Questionnaire; BMI; body mass index; CG; control group; CPET; cardiopulmonary exercise test; e.g.; for example
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy1
Keywords: درمان آندروژن محروم; Prostate cancer; Androgen-deprivation therapy; Depression; Quality of life;
Improving outcomes in high-risk prostate cancer with radiotherapy
Keywords: درمان آندروژن محروم; High-risk prostate cancer; External beam radiation therapy; Androgen-deprivation therapy; Anti-androgen agents; Androgen receptor
Prostate cancer
Keywords: درمان آندروژن محروم; Active surveillance; androgen-deprivation therapy; castrate-resistant prostate cancer; prostate cancer; prostate specific antigen; radical prostatectomy; radical radiotherapy
Progress in emerging therapies for advanced prostate cancer
Keywords: درمان آندروژن محروم; Metastatic castration-resistant prostate cancer; Chemotherapy; Androgen-deprivation therapy; Immunotherapy; Bone metastasis; Bone-targeted agent; Skeletal-related event
Management of Patients with Biochemical Recurrence After Local Therapy for Prostate Cancer
Keywords: درمان آندروژن محروم; Rising prostate-specific antigen; Prostate cancer; Hormonal therapy; Androgen-deprivation therapy; Biochemical recurrence;
Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial
Keywords: درمان آندروژن محروم; Locally advanced prostate cancer; Androgen-deprivation therapy; Combined modality; Radiotherapy
High-Risk Prostate Cancer: From Definition to Contemporary Management
Keywords: درمان آندروژن محروم; Prostate cancer; High-risk prostate cancer; Radical prostatectomy; Radiation therapy; Adjuvant therapy; Biomarker; Androgen-deprivation therapy
CommentaryAntioxidants for prostate cancer chemoprevention: Challenges and opportunities
Keywords: درمان آندروژن محروم; 8-oxo-dG; 8-oxo-2â²-deoxyguanosine; ADT; androgen-deprivation therapy; AR; androgen receptor; ARE; antioxidant response element; ATBC; Alpha-Tocopherol, Beta-Carotene; BPH; benign prostatic hyperplasia; CARET; Carotene and Retinol Efficacy Trial; CRPC; c
Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer
Keywords: درمان آندروژن محروم; Prostate; Androgen-deprivation therapy; Population based; Stroke; Cerebrovascular
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Prostate cancer; Radiotherapy; Combined treatment
Current Approach to Androgen Deprivation Therapy in Patients With Advanced Prostate Cancer
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Prostate cancer; Guidelines; EAU; Intermittent; PSA
Does Local Treatment of the Prostate in Advanced and/or Lymph Node Metastatic Disease Improve Efficacy of Androgen-Deprivation Therapy? A Systematic Review
Keywords: درمان آندروژن محروم; Prostate cancer; Androgen-deprivation therapy
Androgen-Deprivation Therapy in Prostate Cancer: A European Expert Panel Review
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Hormonal therapy; Intermittent therapy; Luteinising hormone-releasing hormone agonist; Prostate cancer; Quality of life
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Keywords: درمان آندروژن محروم; Adjuvant therapy; Androgen-deprivation therapy; Hormone therapy; Neoadjuvant therapy; Prostate cancer; Radical prostatectomy; Radiotherapy;
Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
Keywords: درمان آندروژن محروم; ADT, Androgen deprivation therapy; GnRH, Gonadotropin-releasing hormone; LHRH, Luteinizing hormone-releasing hormone; NK cell, Natural killer cell; PSA, Prostate-specific antigenProstate cancer; Androgen-deprivation therapy; Immunohistochemistry; Computer
Intra-prostatic androgen levels during various androgen-blockade regimens
Keywords: درمان آندروژن محروم; prostate cancer; testosterone; dihydrotestosterone; intra-prostatic androgen metabolism; androgen-deprivation therapy
Highlights on Prostate Cancer from Urological and Oncological Congresses in 2007
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Biopsy; Diagnosis; Hormone therapy; Hormone-refractory prostate cancer; Imaging; Prostate cancer; Nomogram; Radiotherapy; Radical prostatectomy
New Tools for the Urologist in the Management of Patients with Bone Metastases
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Bone metastases; Bone scan; Prostate cancer; Prostate-specific antigen
Risk Factors for the Development of Bone Metastases in Prostate Cancer
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Bone metastases; Prostate-specific antigen
Advances in Oncological Urology-the Oncoforum Programme
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Hormone therapy; Hormone-refractory prostate cancer; Prostate cancer; Prostate-specific antigen; Radical prostatectomy; Radiotherapy;
Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Bisphosphonates; Bone; Bone loss; Bone metastases; Bone mineral density; DEXA; Fracture; Prostate cancer; Zoledronic acid
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer
Keywords: درمان آندروژن محروم; Androgen-deprivation therapy; Bisphosphonates; Bone mineral density; Bone metastases; Fracture; Prostate cancer; Skeletal disease; Skeletal-related events; Spinal cord compression; Radiation to bone; Zoledronic acid
Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy
Keywords: درمان آندروژن محروم; Prostate cancer; Androgen-deprivation therapy; Survival; Brachytherapy;